683 Capital Management’s Leap Therapeutics LPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$429K Sell
1,444,143
-5,757
-0.4% -$1.71K 0.03% 104
2025
Q1
$442K Buy
1,449,900
+99,900
+7% +$30.5K 0.03% 108
2024
Q4
$3.88M Sell
1,350,000
-30,500
-2% -$87.7K 0.24% 61
2024
Q3
$3.55M Buy
1,380,500
+80,500
+6% +$207K 0.27% 63
2024
Q2
$2.55M Buy
1,300,000
+850,000
+189% +$1.67M 0.19% 70
2024
Q1
$1.2M Hold
450,000
0.09% 73
2023
Q4
$1.87M Sell
450,000
-40,000
-8% -$166K 0.15% 65
2023
Q3
$676K Buy
490,000
+185,001
+61% +$255K 0.05% 85
2023
Q2
$955K Buy
304,999
+24,999
+9% +$78.2K 0.07% 86
2023
Q1
$952K Buy
280,000
+5,000
+2% +$17K 0.07% 113
2022
Q4
$1.24M Buy
275,000
+48,500
+21% +$218K 0.1% 105
2022
Q3
$1.99M Buy
226,500
+82,518
+57% +$726K 0.15% 93
2022
Q2
$1.66M Buy
143,982
+52,904
+58% +$608K 0.12% 117
2022
Q1
$1.59M Buy
+91,078
New +$1.59M 0.09% 127
2021
Q1
Sell
-20,077
Closed -$452K 199
2020
Q4
$452K Sell
20,077
-32,570
-62% -$733K 0.02% 121
2020
Q3
$1.04M Hold
52,647
0.08% 83
2020
Q2
$1.1M Buy
52,647
+25,000
+90% +$522K 0.09% 84
2020
Q1
$437K Buy
27,647
+12,633
+84% +$200K 0.05% 91
2019
Q4
$168K Hold
15,014
0.02% 125
2019
Q3
$176K Hold
15,014
0.02% 101
2019
Q2
$268K Hold
15,014
0.02% 105
2019
Q1
$281K Buy
15,014
+14
+0.1% +$262 0.03% 95
2018
Q4
$300K Hold
15,000
0.02% 99
2018
Q3
$1.17M Hold
15,000
0.08% 69
2018
Q2
$1.35M Hold
15,000
0.09% 75
2018
Q1
$1.25M Buy
+15,000
New +$1.25M 0.11% 69